Manufacture of pharmaceutical preparations
VISTIN PHARMA ASA
Operating profit
NOK −6.1m
Equity
NOK 184.0m
Incorporated
2015
Share capital
NOK 44.3m
Key figures · 2024
Current ratio
51.58
Equity ratio
98.6%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -3.2% | |
| Likviditet | ||
| Current ratio | 51.58 | |
| Working capital | 129.2m | |
| Soliditet | ||
| Equity ratio (%%) | 98.6% | |
| Debt-to-equity ratio | 0.01 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.